Facilitated By

San Antonio Medical Foundation

A PHASE 2, OPEN-LABEL, EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF UBENIMEX IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (WHO GROUP 1)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Levine, Deborah Jo
Funded by
EIGER BIOPHARMACEUTICALS, INC.
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Other